| Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity (NCT04966741) | Rhythm Pharmaceuticals, Inc. | 2022-03-08 |
| Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome (NCT05400278) | Oslo University Hospital | 2022-02-01 |
| Phase 3 Crossover Trial of Two Formulations of Setmelanotide in Participants With Specific Gene Defects in the MC4R Pathway (NCT05194124) | Rhythm Pharmaceuticals, Inc. | 2021-12-21 |
| Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) (NCT04874909) | Assistance Publique - Hôpitaux de Paris | 2021-11-08 |
| COhort for Bardet-Bield Syndrome and Alström Syndrome for Translational Research Monocentric Interventional Study (NCT04461444) | University Hospital, Strasbourg, France | 2020-06-16 |
| GROWing Up With Rare GENEtic Syndromes (NCT04463316) | dr. Laura C. G. de Graaff-Herder | 2018-10-01 |
| Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual Improvement (NCT03490019) | University Hospital Tuebingen | 2018-04-01 |
| Clinical Registry Investigating Bardet-Biedl Syndrome (NCT02329210) | Marshfield Clinic Research Foundation | 2014-06-01 |
| Inherited Retinal Degenerative Disease Registry (NCT02435940) | Foundation Fighting Blindness | 2014-06-01 |
| ARPKD Database Study (NCT01401998) | Children's Hospital of Philadelphia | 2011-06-01 |
| Genetics and Clinical Characteristics of Bardet-Biedl Syndrome (NCT00078091) | National Human Genome Research Institute (NHGRI) | 2004-02-17 |
| Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults (NCT00213811) | University Hospital, Strasbourg, France | 2003-06-01 |